Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
09 2020
Historique:
received: 31 10 2019
revised: 29 03 2020
accepted: 09 04 2020
pubmed: 28 4 2020
medline: 9 2 2021
entrez: 28 4 2020
Statut: ppublish

Résumé

Several factors are included in decision making for treatment of patients with locally advanced rectal cancer, including a trade-off between risks and gains of both clinical and functional outcomes. However, it is largely unknown which outcomes are most important to patients and whether this differs between patients and clinicians. Both clinicians and patients treated for locally advanced rectal cancer were invited to fill out an online questionnaire, including a choice-based conjoint experiment. Participants were presented 14 comparisons of two hypothetical case presentations, characterized by different treatments and outcomes of care (6 attributes) and were asked to select the case with the best outcome at that moment. Hierarchical Bayes Estimation was used to calculate the relative importance (RI) of each of the six attributes. In total, 94 patients and 128 clinicians completed the questionnaire. For patients, avoiding surgery with permanent stoma was most important (RI 24.4, 95%CI 21.88-26.87) and a 2-year difference in disease-free survival was least important (RI 5.6, 95%CI 4.9-6.2). Clinicians assigned highest importance to avoiding severe and daily worries about cancer recurrence (RI 30.7, 95%CI 29.1-32.4), while this was ranked 4th by patients (RI 17.9, 95%CI 16.5-19.4, p < 0.001). When confronted with different outcomes within one case description, patients find the duration of disease free survival the least important. In addition, considerable differences were found between the importance assigned by patients and clinicians to clinical and functional outcomes, most notably in avoiding surgery with permanent stoma and worries about recurrence.

Identifiants

pubmed: 32336626
pii: S0748-7983(20)30411-X
doi: 10.1016/j.ejso.2020.04.014
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1634-1641

Informations de copyright

Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Maxime J M van der Valk (MJM)

Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands; Department of Surgery, Antoni van Leeuwenhoek-National Cancer Institute, Amsterdam, the Netherlands. Electronic address: d.e.hilling@lumc.nl.

Marit E van der Sande (ME)

Department of Surgery, Antoni van Leeuwenhoek-National Cancer Institute, Amsterdam, the Netherlands.

Renee E Toebes (RE)

Department of Surgery, Antoni van Leeuwenhoek-National Cancer Institute, Amsterdam, the Netherlands.

Stephanie O Breukink (SO)

Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands; School of Nutrition and Translational Research in Metabolism, Maastricht, the Netherlands.

Mirelle E E Bröker (MEE)

Department of Surgery, IJsselland Hospital, Capelle a/d IJssel, the Netherlands.

Pascal G Doornebosch (PG)

Department of Surgery, IJsselland Hospital, Capelle a/d IJssel, the Netherlands.

Nansi Maliko (N)

Department of Surgery, Alrijne Hospital, Leiderdorp, the Netherlands.

Peter A Neijenhuis (PA)

Department of Surgery, Alrijne Hospital, Leiderdorp, the Netherlands.

Andreas W K S Marinelli (AWKS)

Department of Surgery, Haaglanden Medisch Centrum, Hague, the Netherlands.

Femke P Peters (FP)

Department of Radiotherapy, Antoni van Leeuwenhoek-National Cancer Institute, Amsterdam, the Netherlands; Department of Radiotherapy, Leiden University Medical Centre, Leiden, the Netherlands.

Koen C M J Peeters (KCMJ)

Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

Geerard L Beets (GL)

Department of Surgery, Antoni van Leeuwenhoek-National Cancer Institute, Amsterdam, the Netherlands.

Perla J Marang-van de Mheen (PJ)

Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Centre, Leiden, the Netherlands.

Denise E Hilling (DE)

Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands; Department of Surgery, Antoni van Leeuwenhoek-National Cancer Institute, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH